Cargando…
Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
Triple-negative breast cancer (TNBC), which is largely synonymous with the basal-like molecular subtype, is the 5th leading cause of cancer deaths for women in the United States. The overall prognosis for TNBC patients remains poor given that few treatment options exist; including targeted therapies...
Autores principales: | Turanli, Beste, Karagoz, Kubra, Bidkhori, Gholamreza, Sinha, Raghu, Gatza, Michael L., Uhlen, Mathias, Mardinoglu, Adil, Arga, Kazim Yalcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514249/ https://www.ncbi.nlm.nih.gov/pubmed/31134131 http://dx.doi.org/10.3389/fgene.2019.00420 |
Ejemplares similares
-
Current State of “Omics” Biomarkers in Pancreatic Cancer
por: Turanli, Beste, et al.
Publicado: (2021) -
Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019) -
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022) -
Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018) -
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)